TALLAHASSEE, Fla., Nov. 15, 2012 /PRNewswire/ -- Global Green, Inc. (OTCBB: GOGC) today announced that Dr. Mehran Ghazvini and Dr. Rene Reed will be making a joint presentation on "Creating the world's first in-ovo salmonella vaccine for chicken" at the 2012 World Animal Health Congress, a senior-level B2B conference for animal drug companies, on Wednesday, November 28. Dr. Ghazvini, Chairman and CEO of Global Green, will also be included in a panel session entitled "Improving yields and decreasing disease to meet worldwide food demands." The panel immediately follows the Global Green joint presentation. The Congress, a senior-level B2B conference for animal drug companies to be held November 27 and 28 in Kansas City, Missouri, showcases innovation in animal health, featuring senior-level speakers from the pharma, biotech, diagnostics and government sectors including Novartis, Merial, the USDA and the FDA. It provides an unrivaled platform to expose the most pressing business challenges of the industry. www.terrapinn.com/animalhealth Terrapinn, a business media company and the sponsor for the Congress, will be distributing Global Green's White Paper entitled "Combating the Deadly Effects of Salmonella with Salmogenics" across multiple digital channels, including Twitter, LinkedIn, email blasts promoting the conference, and will be included in Terrapinn's Total BioPharma blog. The White Paper addresses the economic and environmental benefits of the Salmogenics vaccine. Dr. Ghazvini commented, "The World Animal Health Congress is the industry's only global, commercially-focused animal health conference. It is an affirmation of our salmonella vaccine, Salmogenics, that we have been invited to speak at this conference." Salmogenics helps to fight multiple strains of Salmonella bacteria in poultry. It is unique in that it is injected directly into the egg, before the chick is hatched, improving the immune system, health and welfare of the chicken, and providing a healthier source of protein for humans in a cost effective manner.